This surge is driven by India's strong position in Active Pharmaceutical ingredients (API) and generic drug manufacturing, along with cost advantages over China.

The Indian healthcare landscape has long been recognised for its conventional delivery models and value chain. However, in recent years, it has undergone a tremendous change with a growing ...

New Delhi: On this World Cancer Day, the Global Sustainability Alliance (GSA) highlighted the rising number of cancer cases in India, which threatens the country’s goal of becoming a developed ...